Quick Takeaways
- SUVRETTA CAPITAL MANAGEMENT, LLC filed SCHEDULE 13G for Palvella Therapeutics, Inc. Common stock, $0.001 par value per share (PVLA).
- Disclosed ownership: 8.6%.
- Date of event: 13 Dec 2024.
SUVRETTA CAPITAL MANAGEMENT, LLC - 13 Dec 2024 SCHEDULE 13G Report for Palvella Therapeutics, Inc. Common stock, $0.001 par value per share (PVLA)
- Filing Manager
- SUVRETTA CAPITAL MANAGEMENT, LLC
- Reporting Manager
- SUVRETTA CAPITAL MANAGEMENT, LLC
- Symbol
- PVLA
- Shares outstanding
- 8,307,709 shares
- Disclosed Ownership
- 714,463 shares
- Ownership
- 8.6%
- Form type
- SCHEDULE 13G
- Filing time
- 20 Dec 2024, 16:56:34 UTC
- Date of event
- 13 Dec 2024
- Next filing
- 13 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"SUVRETTA CAPITAL MANAGEMENT, LLC disclosed 8.6% ownership in Palvella Therapeutics, Inc. Common stock, $0.001 par value per share (PVLA) on 13 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 20 Dec 2024, 16:56.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 8.6% | 714,463 | 0 | 714,463 | /s/ Aaron Cowen | Aaron Cowen, Authorized Signatory | |
| Averill Master Fund, Ltd. | 8.6% | 714,463 | 0 | 714,463 | /s/ Aaron Cowen | Aaron Cowen, Director | |
| Aaron Cowen | 8.6% | 714,463 | 0 | 714,463 | /s/ Aaron Cowen | Aaron Cowen |